Effect of Jian-Pi-Zhi-Dong Decoction on striatal glutamate and γ-aminobutyric acid levels detected using microdialysis in a rat model of Tourette syndrome

References

• SwainJEScahillLLombrosoPJKingRALeckmanJFTourette syndrome and tic disorders: a decade of progressJ Am Acad Child Adolesc Psychiatry200746894796817667475
   PubMed Web of Science ®Google Scholar
• FellingRJSingerHSNeurobiology of Tourette syndrome: current status and need for further investigationJ Neurosci20113135123871239521880899
   PubMed Web of Science ®Google Scholar
• FreemanRDTic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndromeEur Child Adolesc Psychiatry2007161152317665279
   PubMed Web of Science ®Google Scholar
• HallettMTourette syndrome: updateBrain Dev201537765165525604739
   PubMed Web of Science ®Google Scholar
• NeunerILudolphATic-Störungen und Tourette-Syndrom in der Lebensspanne [Tics and Tourette’s syndrome throughout the life span]Nervenarzt2009801113771387 German19855949
   PubMed Web of Science ®Google Scholar
• SegawaMNeurophysiology of Tourette’s syndrome: pathophysiological considerationsBrain Dev200325Suppl 1S62S6914980375
   PubMed Web of Science ®Google Scholar
• NomuraYSegawaMNeurology of Tourette’s syndrome (TS) TS as a developmental dopamine disorder: a hypothesisBrain Dev200325Suppl 1S37S4214980371
   PubMed Web of Science ®Google Scholar
• SingerHSMorrisCGradosMGlutamatergic modulatory therapy for Tourette syndromeMed Hypotheses201074586286720022434
   PubMed Web of Science ®Google Scholar
• TübingJMünchauACortical GABAergic activity: a mediator of tic control?Mov Disord201530333925758999
   PubMed Web of Science ®Google Scholar
• FontehAHarringtonRTsaiALiaoPHarringtonMGFree amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjectsAmino Acids200732221322417031479
   PubMed Web of Science ®Google Scholar
• GallowayMPGhoddoussiFNeedlemanRBBrusilowWSGlutamate as a target in Tourette syndrome and other neuropsychiatric disordersJ Neurol Sci2010293112612720409560
   PubMed Web of Science ®Google Scholar
• LernerABagicASimmonsJMWidespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndromeBrain Res201213519261936
   Google Scholar
• WangDHLiWLiuXFZhangJMWangSMChinese medicine formula “Jian-Pi-Zhi-Dong Decoction” attenuates Tourette Syndrome via downregulating the expression of dopamine transporter in miceEvid Based Complement Alternat Med2013201338568523431337
   PubMed Web of Science ®Google Scholar
• ZhangWYuWJWangDHWeiLiLeeMKWangSMEffect of “Jian-Pi-Zhi-Dong Decoction” on gamma-aminobutyric acid in a mouse model of Tourette syndromeEvid Based Complement Alternat Med2014201440750924812567
   PubMed Web of Science ®Google Scholar
• YuWJBaiXZhangWWeiLiShiXMWangSMEffects of Jianpi Zhi dong Decoction on the neurotransmitters of tourette syndrome childrenChina J Trad Chin Med Pharm201530517571761
   Google Scholar
• DiamondBIReyeMGBorisonRA new animal model for Tourette syndromeAdv Neurol1982352212256959491
   PubMedGoogle Scholar
• KhanHAAlhomidaASArifIANeurovestibular toxicities of acrylonitrile and iminodipropionitrile in rats: a comparative evaluation of putative mechanisms and target sitesToxicol Sci2009109112413119244277
   PubMed Web of Science ®Google Scholar
• MogwitzSBuseJEhrlichSRoessnerVClinical pharmacology of dopamine-modulating agents in Tourette’s syndromeDavideMAndreaECInternational Review of NeurobiologyNew YorkAcademic Press2013281349
   Google Scholar
• MitchellHAAhernTHLilesLCJavorsMAWeinshenkerDThe effects of norepinephrine transporter inactivation on locomotor activity in miceBiol Psychiatry200660101046105216893531
   PubMed Web of Science ®Google Scholar
• ZhuGeQCThe Rat Brain in Stereotaxic Coordinates3rd edBeijingPeople’s Medical Publishing House2005
   Google Scholar
• GodarSCMosherLJDi GiovanniGBortolatoMAnimal models of tic disorders: a translational perspectiveJ Neurosci Methods2014238546925244952
   PubMed Web of Science ®Google Scholar
• JeffriesKJSchoolerCSchoenbachCHerscovitchPChaseTNBraunARThe functional neuroanatomy of Tourette’s syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic ratesNeuropsychopharmacology20022719210412062910
   PubMed Web of Science ®Google Scholar
• OrthMRothwellJCMotor cortex excitability and comorbidity in Gilles de la Tourette syndromeJ Neurol Neurosurg Psychiatry2009801293418931001
   PubMed Web of Science ®Google Scholar
• OrthMMünchauARothwellJCCorticospinal system excitability at rest is associated with tic severity in Tourette SyndromeBiol Psychiatry200864324825118243162
   PubMed Web of Science ®Google Scholar
• HeiseKFStevenBLiuzziGAltered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndromeBrain2010133Pt 258059020008030
   PubMed Web of Science ®Google Scholar
• BuseJSchoenefeldKMünchauARoessnerVNeuromodulation in Tourette syndrome: dopamine and beyondNeurosci Biobehav Rev20133761069108423085211
   PubMed Web of Science ®Google Scholar
• CoxJHSeriSCavannaAEHistaminergic modulation in Tourette syndromeExpert Opin Orphan Drugs201642205213
   Web of Science ®Google Scholar
• RubensteinJLRMerzenichMMModel of autism: increased ratio of excitation/inhibition in key neural systemsGenes Brain Behav20032525526714606691
   PubMed Web of Science ®Google Scholar
• RamamoorthiKLinYThe contribution of GABAergic dysfunction to neurodevelopmental disordersTrends Mol Med201117845246221514225
   PubMed Web of Science ®Google Scholar
• ClarkeRALeeSEapenVPathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including autismTransl Psychiatry20122e15822948383
   PubMed Web of Science ®Google Scholar
• Jaquins-GerstlAShuZZhangJLiuYWeberSGMichaelACThe effect of dexamethasone on gliosis, ischemia, and dopamine extraction during microdialysis sampling in brain tissueAnal Chem201183207662766721859125
   PubMed Web of Science ®Google Scholar
• NicNiocaillBHaraldssonBHanssonOO’ConnorWTBrundinPAltered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic miceEur J Neurosci200113120621011135020
   PubMed Web of Science ®Google Scholar
• McGrathMJCampbellKMParksCRBurtonFHGlutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorderBrain Res20008771233010980239
   PubMed Web of Science ®Google Scholar
• McNaughtKSMinkJWAdvances in understanding and treatment of Tourette syndromeNat Rev Neurol201171266767622064610
   PubMed Web of Science ®Google Scholar
• KalanithiPSAZhengWKataokaYAltered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndromeProc Natl Acad Sci U S A200510237133071331216131542
   PubMed Web of Science ®Google Scholar
• KataokaYKalanithiPSAGrantzHDecreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette SyndromeJ Comp Neurol2010518327729119941350
   PubMed Web of Science ®Google Scholar
• DraperAStephensonMCJacksonGMIncreased GABA contributes to enhanced control over motor excitability in Tourette syndromeCurr Biol201424192343234725264251
   PubMed Web of Science ®Google Scholar
• JacksonGMDraperADykeKPépésSEJacksonSRInhibition, disinhibition, and the control of action in Tourette syndromeTrends Cogn Sci2015191165566526440120
   PubMed Web of Science ®Google Scholar
• GalvanAKuwajimaMSmithYGlutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?Neuroscience2006143235137517059868
   PubMed Web of Science ®Google Scholar
• DuJCChiuTFLeeKMTourette syndrome in children: an updated reviewPediatr Neonatol201051525526420951354
   PubMed Web of Science ®Google Scholar
• GradosMAAtkinsEBKovacikovaGIMcVicarEA selective review of glutamate pharmacological therapy in obsessive–compulsive and related disordersPsychol Res Behav Manage20158115131
   PubMed Web of Science ®Google Scholar